• Search

    Archive

  • Sign up to mailings

    To keep up to date with our latest news and events, please sign up for mailings.

    You are always free to unsubscribe at any time.

    Sign up

Our Personal Injury & Clinical Negligence teams have created a compelling channel for lawyers which will provide news, insights, and some personality to complex legal cases.

Our podcasts convey thought leadership throughout our episodes, share insights, and simplify and discuss implications of key cases in personal injury and clinical negligence law. We also aim to save solicitors some time in summarising and explaining developments.

Episode 29 –Prognostic issues

In this second of three podcasts in our mini-series looking at the fundamentals in oncology cases, Clinical Negligence barrister Rachel Segal talks to Oncologist Professor Pat Price about Prognostic issues.  Find out more from their discussion about the many factors in reaching an accurate prognosis in oncology, predicting effects on life expectancy and about the concept of conditional survival.

About Professor Pat Price and Dr Rachel Segal

As many of listeners will know, Professor Pat Price is a Consultant Oncologist and a go-to medicolegal expert for both claimants and defendants in clinical negligence litigation.  Professor Price is a pioneer in PET molecular imaging, Visiting Professor at Imperial College London and, among many other activities, runs the charity Radiotherapy UK.  She has been instrumental in establishing the Medicolegal Knowledge Partnership (MLKP) – an important collaborative initiative aiming to improve patient care and legal outcomes in healthcare matters. Here is a link to Medicolegal Knowledge Partnership (MLKP) which lawyers can join for free. Find out more here.

Dr Rachel Segal is a specialist personal injury and clinical negligence barrister advising and representing claimants and defendants in litigation, and interested persons in healthcare-related inquests. Rachel’s busy practice spans the spectrum of clinical negligence, and within her many oncology cases she is particularly experienced in matters involving delayed diagnosis of primary and metastatic breast, colorectal and prostate cancers.  She is ranked as a leading junior in her specialisms in both The Legal 500 and Chambers UK. Find out more here.